Jonathan Allan, GENERAL COUNSEL & Corporate Secretary at Stoke Therapeutics, Inc. (STOK), sold 25,780 shares at $13.69 ($352K) on 2024-12-09, disclosed to the SEC on 2024-12-11.
Scheduled sale ($352k) by GENERAL COUNSEL & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.99 | 1,552 | $20K | 5.7% |
| 2 | $13.69 | 12,114 | $166K | 47.1% |
| 3 | $13.69 | 12,114 | $166K | 47.1% |
| Total | $13.65 avg | 25,780 | $352K | 100% |
| Filing → |
| STOK | SELL | 2026-06-18 | $44K | — | Filing → |
| STOK | SELL | 2026-03-24 | $626K | — | Filing → |
| STOK | SELL | 2026-03-19 | $569K | — | Filing → |